CRBP
Corbus Pharmaceuticals Holding
NASDAQ: CRBP · HEALTHCARE · BIOTECHNOLOGY
$9.82
+0.00% today
Updated 2026-04-29
Market cap
$178.43M
P/E ratio
—
P/S ratio
169.88x
EPS (TTM)
$-5.90
Dividend yield
—
52W range
$6 – $21
Volume
0.2M
Corbus Pharmaceuticals Holding (CRBP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-54.20%
ROA
-32.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-886.00 | — | — | — |
| 2013 | — | $-602350.00 | — | — | — |
| 2014 | $0.00 | $-2.54M | — | — | — |
| 2015 | $648382.00 | $-8.85M | -808.21% | -1,365.51% | -1,365.05% |
| 2016 | $1.91M | $-20.00M | -707.60% | -1,045.56% | -1,046.27% |
| 2017 | $2.44M | $-32.42M | -967.09% | -1,334.43% | -1,328.65% |
| 2018 | $4.82M | $-55.67M | -908.11% | -1,176.78% | -1,154.48% |
| 2019 | $36.14M | $-71.45M | -147.91% | -213.33% | -197.69% |
| 2020 | $3.94M | $-111.27M | 100.00% | -3,119.20% | -2,826.08% |
| 2021 | $881705.00 | $-45.55M | -85.92% | -6,350.09% | -5,166.42% |
| 2022 | $0.00 | $-55.83M | — | — | — |
| 2023 | $0.00 | $-44.60M | — | — | — |
| 2024 | $0.00 | $-40.21M | — | — | — |
| 2025 | $0.00 | $-78.54M | — | — | — |